Literature DB >> 18614267

Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice.

James J Pestka1, Chidozie J Amuzie.   

Abstract

The frequent presence of deoxynivalenol (DON) in cereal-based foods and the high intake of these foods by children raises particular concerns about the relative susceptibility of this subpopulation to adverse effects evoked by this mycotoxin. We tested the hypothesis that both toxicokinetics and proinflammatory cytokine gene expression following a oral DON exposure at 5mg/kg bw differ between weanling (3-4 wk) and young adult (8-10 wk) female mice. DON was rapidly taken up with maximum plasma concentrations reaching 1.0 microg/ml in adult mice at 15 min, whereas DON levels were approximately twice as much in weanling mice at these times. DON was rapidly cleared in both weanling and adult mice with concentrations being reduced by 78% and 81% of the peak levels, respectively, after 2h. DON accumulation and clearance in spleen, liver, lung and kidney followed similar kinetics to that of plasma with tissue burdens also reaching twice that of adult mice. When TNF-alpha, IL-1beta and IL-6 mRNAs in spleens (a primary source of systemic proinflammatory cytokines) were used as biomarkers of the DON's effects, expression of these mRNAs was two to three times greater in weanling than adult mouse. However, differences in proinflammatory cytokine expression were less robust or not apparent in the liver or lung. Taken together, these data suggest that young mice are modestly more susceptible than adult mice to the adverse effects of DON and that this might result from a greater toxin tissue burden.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614267      PMCID: PMC2620205          DOI: 10.1016/j.fct.2008.05.016

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  36 in total

1.  Induction of cytokine mRNAs in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): relationship to toxin distribution and protein synthesis inhibition.

Authors:  J I Azcona-Olivera; Y Ouyang; J Murtha; F S Chu; J J Pestka
Journal:  Toxicol Appl Pharmacol       Date:  1995-07       Impact factor: 4.219

2.  The role of gut micro-organisms in the metabolism of deoxynivalenol administered to rats.

Authors:  N R Worrell; A K Mallett; W M Cook; N C Baldwin; M J Shepherd
Journal:  Xenobiotica       Date:  1989-01       Impact factor: 1.908

Review 3.  Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox.

Authors:  James J Pestka; Hui-Ren Zhou; Y Moon; Y J Chung
Journal:  Toxicol Lett       Date:  2004-10-10       Impact factor: 4.372

Review 4.  Report from SCOOP task 3.2.10 "collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states". Subtask: trichothecenes.

Authors:  Ronald C Schothorst; Hans P van Egmond
Journal:  Toxicol Lett       Date:  2004-10-10       Impact factor: 4.372

5.  Lack of hepatic microsomal metabolism of deoxynivalenol and its metabolite, DOM-1.

Authors:  L M Côté; W Buck; E Jeffery
Journal:  Food Chem Toxicol       Date:  1987-04       Impact factor: 6.023

6.  Metabolic fate and elimination in milk, urine and bile of deoxynivalenol following administration to lactating sheep.

Authors:  D B Prelusky; D M Veira; H L Trenholm; B C Foster
Journal:  J Environ Sci Health B       Date:  1987-04       Impact factor: 1.990

7.  Comparative cytotoxicity of deoxynivalenol, nivalenol, their acetylated derivatives and de-epoxy metabolites.

Authors:  G Sundstøl Eriksen; H Pettersson; T Lundh
Journal:  Food Chem Toxicol       Date:  2004-04       Impact factor: 6.023

8.  Immunochemical assessment of mycotoxins in 1989 grain foods: evidence for deoxynivalenol (vomitoxin) contamination.

Authors:  M M Abouzied; J I Azcona; W E Braselton; J J Pestka
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

9.  Synthesis and characterization of deoxynivalenol glucuronide: its comparative immunotoxicity with deoxynivalenol.

Authors:  Xianai Wu; Patricia Murphy; Joan Cunnick; Suzanne Hendrich
Journal:  Food Chem Toxicol       Date:  2007-04-11       Impact factor: 6.023

10.  Metabolism of three trichothecene mycotoxins, T-2 toxin, diacetoxyscirpenol and deoxynivalenol, by bovine rumen microorganisms.

Authors:  S P Swanson; J Nicoletti; H D Rood; W B Buck; L M Cote; T Yoshizawa
Journal:  J Chromatogr       Date:  1987-03-06
View more
  28 in total

1.  Effects of oral exposure to naturally-occurring and synthetic deoxynivalenol congeners on proinflammatory cytokine and chemokine mRNA expression in the mouse.

Authors:  Wenda Wu; Kaiyu He; Hui-Ren Zhou; Franz Berthiller; Gerhard Adam; Yoshiko Sugita-Konishi; Maiko Watanabe; Anthony Krantis; Tony Durst; Haibin Zhang; James J Pestka
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-29       Impact factor: 4.219

2.  Kinetics of satratoxin g tissue distribution and excretion following intranasal exposure in the mouse.

Authors:  Chidozie J Amuzie; Zahidul Islam; Jae Kyung Kim; Ji-Hyun Seo; James J Pestka
Journal:  Toxicol Sci       Date:  2010-05-13       Impact factor: 4.849

Review 3.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

4.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Brenna Flannery; Hui-Ren Zhou; Jane E Link; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2013-03-01       Impact factor: 4.849

5.  Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY.

Authors:  Brenna M Flannery; Erica S Clark; James J Pestka
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

6.  Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse.

Authors:  Chidozie J Amuzie; Junko Shinozuka; James J Pestka
Journal:  Toxicol Sci       Date:  2009-07-22       Impact factor: 4.849

7.  Global protein phosphorylation dynamics during deoxynivalenol-induced ribotoxic stress response in the macrophage.

Authors:  Xiao Pan; Douglas A Whitten; Ming Wu; Christina Chan; Curtis G Wilkerson; James J Pestka
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-23       Impact factor: 4.219

8.  Role of GRP78/BiP degradation and ER stress in deoxynivalenol-induced interleukin-6 upregulation in the macrophage.

Authors:  Yuhui Shi; Katie Porter; Narayanan Parameswaran; Hee Kyong Bae; James J Pestka
Journal:  Toxicol Sci       Date:  2009-03-31       Impact factor: 4.849

Review 9.  Advances in deoxynivalenol toxicity mechanisms: the brain as a target.

Authors:  Marion S Bonnet; Julien Roux; Lourdes Mounien; Michel Dallaporta; Jean-Denis Troadec
Journal:  Toxins (Basel)       Date:  2012-11-01       Impact factor: 4.546

10.  Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated response.

Authors:  Patricia M Cano; Julie Seeboth; François Meurens; Juliette Cognie; Roberta Abrami; Isabelle P Oswald; Laurence Guzylack-Piriou
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.